Literature DB >> 18693193

Cancer stem cells: the seeds of metastasis?

Elaine M Hurt1, William L Farrar.   

Abstract

Mesh：

Year:  2008        PMID： 18693193     DOI： 10.1124/mi.8.3.7

Source DB:  PubMed          Journal:  Mol Interv        ISSN： 1534-0384


× No keyword cloud information.
  11 in total

1.  In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker.

Authors:  Nidaa Ababneh; Walhan Alshaer; Omar Allozi; Azmi Mahafzah; Mohammed El-Khateeb; Hervé Hillaireau; Magali Noiray; Elias Fattal; Said Ismail
Journal:  Nucleic Acid Ther       Date:  2013-10-30       Impact factor: 5.486

Review 2.  Diverse involvement of EZH2 in cancer epigenetics.

Authors:  Pamela Völkel; Barbara Dupret; Xuefen Le Bourhis; Pierre-Olivier Angrand
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

3.  Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.

Authors:  Mingli Han; Manran Liu; Yimeng Wang; Zhiqiang Mo; Xiaokai Bi; Zhirong Liu; Yuanming Fan; Xin Chen; Chengyi Wu
Journal:  Mol Cell Biochem       Date:  2011-12-21       Impact factor: 3.396

Review 4.  [Liver metastases: pathogenesis and oncogenesis].

Authors:  U F Wellner; T Keck; T Brabletz
Journal:  Chirurg       Date:  2010-06       Impact factor: 0.955

5.  BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer.

Authors:  Francesco Crea; Maria A Duhagon Serrat; Elaine M Hurt; Suneetha B Thomas; Romano Danesi; William L Farrar
Journal:  Int J Cancer       Date:  2011-04-15       Impact factor: 7.396

6.  Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.

Authors:  Christel van den Hoogen; Geertje van der Horst; Henry Cheung; Jeroen T Buijs; Rob C M Pelger; Gabri van der Pluijm
Journal:  Am J Pathol       Date:  2011-09-09       Impact factor: 4.307

Review 7.  Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

8.  Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.

Authors:  Lusheng Xu; Yeon-Jin Kwon; Natalya Frolova; Adam D Steg; Kun Yuan; Martin R Johnson; William E Grizzle; Renee A Desmond; Andra R Frost
Journal:  Breast Cancer Res Treat       Date:  2009-11-10       Impact factor: 4.872

Review 9.  Metastasis: new perspectives on an old problem.

Authors:  Sandra Kraljevic Pavelic; Mirela Sedic; Hrvojka Bosnjak; Sime Spaventi; Kresimir Pavelic
Journal:  Mol Cancer       Date:  2011-02-22       Impact factor: 27.401

10.  Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer.

Authors:  Francesco Crea; Elaine M Hurt; Lesley A Mathews; Stephanie M Cabarcas; Lei Sun; Victor E Marquez; Romano Danesi; William L Farrar
Journal:  Mol Cancer       Date:  2011-04-18       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.